The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes
Open accessAbstract
OBJECTIVE—To examine whether changes characteristic of Alzheimer's disease occur in two rat models with spontaneous onset of type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS—The frontal cortices of 8-month-diabetic rats were examined with respect to neuronal densities, neurite degeneration, expression, and/or immunolocalization of amyloid precursor protein (APP), β-secretase, β-amyloid, COOH-terminal fragment (CTF), insulin receptor, IGF-1 receptor, glycogen synthase kinase 3-β (GSK-3β), protein kinase B (Akt), phosphorylated τ (phospho-τ), synaptophysin, and phosphorylated neurofilaments (SMI-31). RESULTS—Neuronal loss occurred in both models, significantly more so in type 2 diabetic BBZDR/Wor rats compared with type 1 diabetic BB/Wor rats and was associated with a ninefold increase of dystrophic neurites. APP, β-secretase, β-amyloid, and CTF were significantly increased in type 2 diabetic rats, as was phospho-τ. The insulin receptor expression was decreased in type 1 diabetes, whereas IGF-1 receptor was decreased in both models, as were Akt and GSK-3β expression. CONCLUSIONS—The data show that β-amyloid and phospho-τ accumulation occur in experimental diabetes and that this is associated with neurite degeneration and neuronal loss. The changes were more severe in the type 2 diabetic model and appear to be associated with insulin resistance and possibly hypercholesterolemia. The two models will provide useful tools to unravel further mechanistic associations between diabetes and Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ghribi, O., Larsen, B., Schrag, M., & Herman, M. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.019 · Cited by 151
RetractedThe Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775
Tau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Ho, L., Qin, W., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C. V., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 630
Clearing the brain's amyloid cobwebs
Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 492
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 434
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
Biessels, G.-J., Kamal, A., Urban, I. J. A., Spruijt, B. M., Erkelens, D. W., & Gispen, W. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00510-1 · Cited by 379
Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models
Patel, N. V., Gordon, M. N., Connor, K. E., Good, R. A., Engelman, R. W., Mason, J., Morgan, D. G., Morgan, T. E., & Finch, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.014 · Cited by 329
Hippocampal neuronal apoptosis in type 1 diabetes
Li, Z.-G., Zhang, W., Grunberger, G., & Sima, A. A. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02887-1 · Cited by 316
Self-citationCausative and susceptibility genes for Alzheimer’s disease: a review
Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00067-4 · Cited by 316
Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease
Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K., Dolios, G., Wang, R., Hof, P. R., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3182fje · Cited by 316
Carro, E., & Torres-Aleman, I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.050 · Cited by 262
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
Riddell, D. R., Christie, G., Hussain, I., & Dingwall, C. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00394-3 · Cited by 253
Salkovic‐Petrisic, M., Tribl, F., Schmidt, M., Hoyer, S., & Riederer, P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03637.x · Cited by 221
Role of caveolin and caveolae in insulin signaling and diabetes
Cohen, A. W., Combs, T. P., Scherer, P. E., & Lisanti, M. P. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00324.2003 · Cited by 220
Nystrom, F. H. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2013 · Cited by 203
Lovestone, S., Hartley, C. L., Pearce, J., & Anderton, B. H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00126-1 · Cited by 201
Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes
Sima, A. A. F., Kamiya, H., & Guo Li, Z. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.056 · Cited by 186
Self-citationQiu, C., Winblad, B., Viitanen, M., & Fratiglioni, L. (2003) · Stroke · doi:10.1161/01.str.0000060127.96986.f4 · Cited by 184
Solano, D. C., Sironi, M., Bonfini, C., Solerte, S. B., Govoni, S., & Racchi, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.1015 · Cited by 177
Effect of Diabetes Mellitus on the Permeability of the Blood–Brain Barrier to Insulin
Banks, W. A., Jaspan, J. B., & Kastin, A. J. (1997) · Peptides · doi:10.1016/s0196-9781(97)00238-6 · Cited by 148
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors
Busiguina, S., Fernandez, A. M., Barrios, V., Clark, R., Tolbert, D. L., Berciano, J., & Torres‐Alemán, I. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0311 · Cited by 145
The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats
Sima, A. A. F., & Li, Z.-G. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1497 · Cited by 145
Self-citationThe Insulin Receptor Catalyzes the Tyrosine Phosphorylation of Caveolin-1
Kimura, A., Mora, S., Shigematsu, S., Pessin, J. E., & Saltiel, A. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203375200 · Cited by 128
Glycogen Synthase Kinase 3β Induces Caspase-cleaved Tau Aggregation in Situ
Cho, J., & Johnson, G. V. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403364200 · Cited by 118
Gray, C. W., & Patel, A. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90037-p · Cited by 117
Kramer, L., Fasching, P., Madl, C., Schneider, B., Damjancic, P., Waldhäusl, W., Irsigler, K., & Grimm, G. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1909 · Cited by 112
PEDERSEN, W., & FLYNN, E. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.003 · Cited by 108
The role of impaired insulin/IGF action in primary diabetic encephalopathy
Li, Z.-G., Zhang, W., & Sima, A. A. F. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.063 · Cited by 84
Self-citationHaley, R. W., & Dietschy, J. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1410 · Cited by 74
Sima, A., Zhang, W., Li, Z.-G., Murakawa, Y., & Pierson, C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1556 · Cited by 71
Self-citationNeuropathology: The Diagnostic Approach
Kim, J. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00016 · Cited by 71
Petanceska, S. S., & Gandy, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732316.x · Cited by 58
Lambourne, S. L., Sellers, L. A., Bush, T. G., Choudhury, S. K., Emson, P. C., Suh, Y., & Wilkinson, L. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.278-293.2005 · Cited by 51
Lin, B., Ginsberg, M. D., & Busto, R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03023-7 · Cited by 39
García, J. Y. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199802000-00011 · Cited by 32
Genetic testing for Alzheimerʼs disease: how close is reality?
Blennow, K., & Skoog, I. G. (1999) · Current Opinion in Psychiatry · doi:10.1097/00001504-199907000-00019 · Cited by 15
Cited by
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Cognitive Dysfunction and Diabetes Mellitus
Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 802
Blázquez, E., Velázquez, E., Hurtado-Carneiro, V., & Ruiz-Albusac, J. M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00161 · Cited by 491
How does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492
Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., & Panza, F. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.007 · Cited by 357
Metadata
- Authors
- Li, Z.-G., Zhang, W., & Sima, A. A. F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-07-01
- Volume
- 56
- Issue
- 7
- Pages
- 1817-1824
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2098757266
- Cited by
- 265
- References
- 47
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.